share_log

Enveric Biosciences Announces Pharmacology and Safety Data For EB-003, Says 'In Vitro Pharmacology Studies Confirmed EB-003's Ability to Target Desired Serotonergic Receptors'

Benzinga ·  Oct 15 20:06
Enveric Biosciences Announces Pharmacology and Safety Data For EB-003, Says 'In Vitro Pharmacology Studies Confirmed EB-003's Ability to Target Desired Serotonergic Receptors'
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment